Sarcoid-Like Granulomatosis Induced by Nivolumab Treatment in a Lung Cancer Patient

Nivolumab, an anti-PD-1 antibody, inhibits binding between PD-1 and PD-1 ligand and activates antigen-specific T cells that have become unresponsive to cancer cells. Although it is recommended as a second-line therapy in gene mutation-negative non-small-cell lung cancer, interstitial pneumonia is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Noguchi, Susumu, Kawachi, Hiroaki, Yoshida, Hiroshi, Fukao, Akari, Terashita, Satoshi, Ikeue, Tatsuyoshi, Horikawa, Sadao, Sugita, Takakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120371/
https://www.ncbi.nlm.nih.gov/pubmed/30186140
http://dx.doi.org/10.1159/000492383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120371/
https://www.ncbi.nlm.nih.gov/pubmed/30186140
http://dx.doi.org/10.1159/000492383

Ejemplares similares